Gossamer Bio Inc., of San Diego, said it priced its IPO of 17.25 million shares at $16 each for expected gross proceeds of $276 million. In addition, the company has granted the underwriters a 30-day option to purchase up to an additional 2.58 million shares at the IPO price. The shares are trading on the Nasdaq under the ticker symbol GOSS.